Cardiomyoplasty does not preclude heart transplantation.

Area of Science:

• Cardiology
• Surgical Innovation
• Biomedical Engineering

Background:

• Stimulated skeletal muscle grafts (cardiomyoplasty) are explored to enhance left ventricle function in severe myocardial failure.
• This surgical technique aims to augment cardiac contractility using the patient's own muscle.
• Previous studies suggest potential benefits in select heart failure patients.

Observation:

• A case of cardiomyoplasty using latissimus dorsi muscle showed initial improvement in left ventricle function.
• Postoperative improvement was transient, with heart failure recurrence after 9 months despite vigorous muscle contraction.
• Intraoperative assessment confirmed muscle viability, yet its function was insufficient for the severely dilated cardiomyopathy.

Findings:

• Histopathological examination revealed good muscle transformation, indicating successful graft preparation.
• Severe cardiac dilation was identified as a significant limitation to the long-term efficacy of cardiomyoplasty.
• The patient subsequently underwent and successfully received a heart transplant.

Implications:

• Cardiomyoplasty failure does not preclude subsequent heart transplantation.
• Severe cardiac dilation is a critical factor to consider when evaluating patients for cardiomyoplasty.
• Histochemical studies support the electrophysiologic principles underlying cardiomyoplasty in human subjects.